Haemonetics Corp (HAE)
77.18
+1.74
(+2.31%)
USD |
NYSE |
Dec 23, 16:00
75.51
-1.67
(-2.16%)
After-Hours: 20:00
Haemonetics Cash from Investing (Quarterly): -23.37M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| ResMed Inc | 2.146M |
| Globus Medical Inc | -14.97M |
| Baxter International Inc | -164.00M |
| Abbott Laboratories | -594.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 48.82M |
| Cash from Financing (Quarterly) | -74.80M |
| Free Cash Flow | 20.35M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 38.02M |
| Free Cash Flow to Firm (Quarterly) | 44.68M |
| Free Cash Flow Yield | 0.51% |